LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 68.37 | 27.76 | 9102 | 6879 | 1.3231 | 1.0717 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.08 | 27.76 | 6920 | 6849 | 1.0103 | 1.0026 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.08 | 27.76 | 7088 | 6849 | 1.0348 | 1.0086 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.08 | 27.76 | 9040 | 6849 | 1.3198 | 1.0711 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.08 | 27.76 | 9194 | 6849 | 1.3422 | 1.0755 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 71.78 | 27.76 | 6984 | 6893 | 1.0132 | 1.0033 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 71.78 | 27.76 | 7192 | 6893 | 1.0434 | 1.0107 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 71.78 | 27.76 | 9158 | 6893 | 1.3286 | 1.0727 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 71.78 | 27.76 | 9355 | 6893 | 1.3571 | 1.0783 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 73.48 | 27.76 | 7073 | 6957 | 1.0166 | 1.0041 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 73.48 | 27.76 | 7369 | 6957 | 1.0591 | 1.0145 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 73.48 | 27.76 | 9170 | 6957 | 1.3179 | 1.0705 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 73.48 | 27.76 | 9408 | 6957 | 1.3522 | 1.0772 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 75.19 | 27.76 | 7144 | 7015 | 1.0184 | 1.0046 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 75.19 | 27.76 | 7488 | 7015 | 1.0674 | 1.0164 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 75.19 | 27.76 | 9195 | 7015 | 1.3107 | 1.0690 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 75.19 | 27.76 | 9501 | 7015 | 1.3544 | 1.0775 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 76.89 | 27.76 | 6673 | 7025 | 0.9499 | 0.9872 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 76.89 | 27.76 | 7589 | 7025 | 1.0803 | 1.0194 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 76.89 | 27.76 | 9126 | 7025 | 1.2990 | 1.0666 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 76.89 | 27.76 | 9555 | 7025 | 1.3601 | 1.0786 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 78.60 | 27.76 | 6047 | 7045 | 0.8582 | 0.9621 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 78.60 | 27.76 | 7728 | 7045 | 1.0968 | 1.0233 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 78.60 | 27.76 | 9045 | 7045 | 1.2837 | 1.0635 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 78.60 | 27.76 | 9652 | 7045 | 1.3699 | 1.0804 | MN20160318_Q01 | J07 |